Germany’s hybrid CRO-biotech Evotec has had a better few months than expected as it announces stronger profits for 2016 ahead of its half-year results on Aug.…

CRO giant Parexel has seen its chief financial officer and senior vice president Ingo Bank resign from the company over the weekend, according to a SEC filing.

The personal genome company 23andMe has launched a new platform that will allow researchers to see and track certain genetic information from patients in their…

Israeli biotech Pluristem Therapeutics has chosen a “leading, global” CRO to help run its Phase I blood cancer trial--but the company is a little shy on…

Drilling deeper into its drug discovery platform, hybrid biotech-CRO Evotec has signed a deal with British charity Antibiotic Research UK to help older…

Two major academic medical centers have been given a 7-year, $26.5 million cash boost from the U.S. government to help weed out inefficiencies in clinical…

San Bruno, CA-based PRC Clinical is expanding both its gene therapy and Parkinson's disease offerings for an undisclosed Boston sponsor.

Germany’s Evotec has penned a new deal with a leading U.S. university that will see it gain access to one of the hottest tickets in drug development: CRISPR…